NR1H4 and Hepatic steatosis: In this study, we found that BBR treatment significantly improves hepatic steatosis and inflammation, as well as dyslipidemia in NASH mice, and beneficial effects are associated with the regulation of gut microbiota and BA metabolism, which further activate intestinal FXR and promote FGF15 secretion.